1. Global Cancer Biomarkers Market 2015-2019 www.technavio.com enquiry@technavio.com

2. USA – CANADA – UK – CHINA – INDIA Global Cancer Biomarkers Market 2015-2019 The report discusses the following in-depth: Market Segmentation by Product Market Segmentation by Nature of Transaction Demographic Segmentation Service Segmentation Business Segmentation by Revenue Geographical Segmentation by Revenue For more information on the Global Cancer Biomarkers Market 2015-2019, please mail us at media@technavio.com

3. USA – CANADA – UK – CHINA – INDIA Key Trends TechNavio’s senior analyst says, “Though the market faces certain challenges, several emerging trends are expected to facilitate its growth during the forecast period. For instance, the growing popularity of companion diagnostics is enabling physicians to make better treatment decisions. Also, increased demand for personalized medicines is another trend being witnessed in the market.” Biomarkers are molecules that are found in blood, other body fluids such as serum and urine, and tissue. They indicate the presence of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. They help in identifying potential drug failures in the initial stages of develop, so they help in saving time and cost. Biomarkers are becoming an essential part of the drug discovery process. The market is growing at a rapid pace and is expected to witness an improvement in its growth rate, posting a CAGR of 18.26 percent during the forecast period.

4. Understanding the key drivers influencing the market Understanding the challenges faced by the market Activities of various stakeholders involved Enabling technologies and the roadmap Key focus areas for the vendors Major trends that will shape the future of this market Vendor landscape and trajectory of the market Conclusion Scope of The Report A detailed analysis of each market driver, challenge and trend is available in our report: Global Cancer Biomarkers Market 2015-2019

5. USA – CANADA – UK – CHINA – INDIA Vendor Landscape For a full list of vendors view our report, Global Cancer Biomarkers Market 2015-2019 Abbott Laboratories Affymetrix Illumina Abbott Laboratories has the largest geographical presence in this market, and its products are available in the US, Europe, and Japan and other countries in the APAC region. The company derives about 30 percent of its sales from the US, 40 percent from emerging markets, and 30 percent from other developing markets. Affymetrix enables multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of research into clinical and routine use for human health. Illumina provides sequencing and array-based solutions in oncology to identify molecular changes in a tumor. The company recently entered into an agreement with Cypher Genomics to facilitate the development of genomic- based biomarkers from whole genome sequence data for personalized medicine.

6. USA – CANADA – UK – CHINA – INDIA Market Landscape The detection of cancer has emerged as a leading diagnostic application of biomarkers worldwide because of the growing number of cancer biomarkers receiving regulatory approval. The ability of biomarkers to shorten drug development time and decrease costs over the long term is encouraging large biotech and pharma companies to employ the use of biomarkers in their R&D processes. The emergence of new companies providing advanced technology platforms in areas such as genomics, bioinformatics, and proteomics is contributing to the growth of the Global Cancer Biomarkers market.

7. USA – CANADA – UK – CHINA – INDIA Key Buying Criteria Guest Bloggers Authenticity Delivery Price Service Support ParametersDetails Accuracy The ability of biomarkers to accurately analyze the diagnostic sample Cost The cost of analyses involving the use of biomarkers Efficacy The ability of biomarkers to effectively correlate with disease diagnosis and progression

8. Growth Forecasts? Market Analysis? Revenue Forecasts? Regional and Country level Analysis? Competitive Structure? Emerging Trends? Vendor Landscape? Other? How would you like to engage with TechNavio? Global Cancer Biomarkers Market 2015-2019

9. USA – CANADA – UK – CHINA – INDIA Reports Cover : Market Scenarios, Vendor landscape & Industry Road Maps. Option to Customize Report & Access to Analysts on every Report Purchase. Reports Cover : Market Scenarios, Vendor landscape & Industry Road Maps. Option to Customize Report & Access to Analysts on every Report Purchase. Option to Customize Reports Ask an Analyst Or Inform us by e-mailing enquiry@technavio.com

10. USA – CANADA – UK – CHINA – INDIA Access the Report USA – CANADA – UK – CHINA – INDIA India: An Overview USA – CANADA – UK – CHINA – INDIA About Us USA – CANADA – UK – CHINA – INDIA Thank You! North America Chicago, USA Phone: +1 630 333 9501 Fax: +1 630 833 2171 Europe London, United Kingdom Phone: +44 208 123 1770 Fax: +44 845 280 2825 Asia Bangalore, India Phone: +91 934 254 0560 Fax: +91 80 4080 6070 DISCLAIMER This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages. Copyright ©2013 Infiniti Research Limited. All Rights Reserved. Reproduction without written permission is completely forbidden. NOT FOR FURTHER DISTRIBUTION